119 related articles for article (PubMed ID: 9639407)
1. Antisense inhibition of urokinase: effect on malignancy in a human osteosarcoma cell line.
Haeckel C; Krueger S; Roessner A
Int J Cancer; 1998 Jul; 77(1):153-60. PubMed ID: 9639407
[TBL] [Abstract][Full Text] [Related]
2. [Antisense inhibition of urokinase in a human osteosarcoma cell line].
Haeckel C; Krueger S; Roessner A
Verh Dtsch Ges Pathol; 1998; 82():170-7. PubMed ID: 10095429
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effects of antisense cathepsin B cDNA transfection on invasion and motility in a human osteosarcoma cell line.
Krueger S; Haeckel C; Buehling F; Roessner A
Cancer Res; 1999 Dec; 59(23):6010-4. PubMed ID: 10606250
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effect of antisense aminopeptidase N (APN/CD13) cDNA transfection on the invasive potential of osteosarcoma cells.
Kido A; Krueger S; Haeckel C; Roessner A
Clin Exp Metastasis; 2003; 20(7):585-92. PubMed ID: 14669789
[TBL] [Abstract][Full Text] [Related]
5. Cathepsin L antisense oligonucleotides in a human osteosarcoma cell line: effects on the invasive phenotype.
Krueger S; Kellner U; Buehling F; Roessner A
Cancer Gene Ther; 2001 Jul; 8(7):522-8. PubMed ID: 11498774
[TBL] [Abstract][Full Text] [Related]
6. Stable expression of antisense urokinase mRNA inhibits the proliferation and invasion of human hepatocellular carcinoma cells.
Tavian D; Salvi A; De Petro G; Barlati S
Cancer Gene Ther; 2003 Feb; 10(2):112-20. PubMed ID: 12536199
[TBL] [Abstract][Full Text] [Related]
7. Stable transfection of urokinase-type plasminogen activator antisense construct modulates invasion of human glioblastoma cells.
Mohanam S; Jasti SL; Kondraganti SR; Chandrasekar N; Kin Y; Fuller GN; Lakka SS; Kyritsis AP; Dinh DH; Olivero WC; Gujrati M; Yung WK; Rao JS
Clin Cancer Res; 2001 Aug; 7(8):2519-26. PubMed ID: 11489835
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of urokinase receptor increases matrix invasion without altering cell migration in a human osteosarcoma cell line.
Karikó K; Kuo A; Boyd D; Okada SS; Cines DB; Barnathan ES
Cancer Res; 1993 Jul; 53(13):3109-17. PubMed ID: 8391387
[TBL] [Abstract][Full Text] [Related]
9. In vitro inhibition of human glioblastoma cell line invasiveness by antisense uPA receptor.
Mohanam S; Chintala SK; Go Y; Bhattacharya A; Venkaiah B; Boyd D; Gokaslan ZL; Sawaya R; Rao JS
Oncogene; 1997 Mar; 14(11):1351-9. PubMed ID: 9178895
[TBL] [Abstract][Full Text] [Related]
10. Co-expression of urokinase-type plasminogen activator and its receptor in human gastric-cancer cell lines correlates with their invasiveness and tumorigenicity.
Park IK; Kim BJ; Goh YJ; Lyu MA; Park CG; Hwang ES; Kook YH
Int J Cancer; 1997 May; 71(5):867-73. PubMed ID: 9180158
[TBL] [Abstract][Full Text] [Related]
11. Kaempferol suppresses cell metastasis via inhibition of the ERK-p38-JNK and AP-1 signaling pathways in U-2 OS human osteosarcoma cells.
Chen HJ; Lin CM; Lee CY; Shih NC; Peng SF; Tsuzuki M; Amagaya S; Huang WW; Yang JS
Oncol Rep; 2013 Aug; 30(2):925-32. PubMed ID: 23708932
[TBL] [Abstract][Full Text] [Related]
12. Urokinase-dependent angiogenesis in vitro and diacylglycerol production are blocked by antisense oligonucleotides against the urokinase receptor.
Fibbi G; Caldini R; Chevanne M; Pucci M; Schiavone N; Morbidelli L; Parenti A; Granger HJ; Del Rosso M; Ziche M
Lab Invest; 1998 Sep; 78(9):1109-19. PubMed ID: 9759655
[TBL] [Abstract][Full Text] [Related]
13. Mouse L cells expressing human prourokinase-type plasminogen activator: effects on extracellular matrix degradation and invasion.
Cajot JF; Schleuning WD; Medcalf RL; Bamat J; Testuz J; Liebermann L; Sordat B
J Cell Biol; 1989 Aug; 109(2):915-25. PubMed ID: 2503527
[TBL] [Abstract][Full Text] [Related]
14. The effect of antisense inhibition of urokinase receptor in human squamous cell carcinoma on malignancy.
Kook YH; Adamski J; Zelent A; Ossowski L
EMBO J; 1994 Sep; 13(17):3983-91. PubMed ID: 8076594
[TBL] [Abstract][Full Text] [Related]
15. Establishment of new multidrug-resistant human osteosarcoma cell lines.
Oda Y; Matsumoto Y; Harimaya K; Iwamoto Y; Tsuneyoshi M
Oncol Rep; 2000; 7(4):859-66. PubMed ID: 10854558
[TBL] [Abstract][Full Text] [Related]
16. Detection of mRNAs for urokinase-type plasminogen activator, its receptor, and type 1 inhibitor in giant cell tumors of bone with in situ hybridization.
Zheng MH; Fan Y; Panicker A; Smith A; Robertson T; Wysocki S; Robbins P; Papadimitriou JM; Wood DJ
Am J Pathol; 1995 Dec; 147(6):1559-66. PubMed ID: 7495280
[TBL] [Abstract][Full Text] [Related]
17. Over-expression of urokinase receptor in human epidermoid-carcinoma cell line (HEp3) increases tumorigenicity on chorio-allantoic membrane and in severe-combined-immunodeficient mice.
Lyu MA; Choi YK; Park BN; Kim BJ; Park IK; Hyun BH; Kook YH
Int J Cancer; 1998 Jul; 77(2):257-63. PubMed ID: 9650562
[TBL] [Abstract][Full Text] [Related]
18. Role of urokinase and its receptor in basal and stimulated colonic epithelial cell migration in vitro.
Wilson AJ; Gibson PR
Gut; 2000 Jul; 47(1):105-11. PubMed ID: 10861271
[TBL] [Abstract][Full Text] [Related]
19. Phyllanthus urinaria suppresses human osteosarcoma cell invasion and migration by transcriptionally inhibiting u-PA via ERK and Akt signaling pathways.
Lu KH; Yang HW; Su CW; Lue KH; Yang SF; Hsieh YS
Food Chem Toxicol; 2013 Feb; 52():193-9. PubMed ID: 23201449
[TBL] [Abstract][Full Text] [Related]
20. Regulation of plasminogen activation, matrix metalloproteinases and urokinase-type plasminogen activator-mediated extracellular matrix degradation in human osteosarcoma cell line MG63 by interleukin-1 alpha.
de Bart AC; Quax PH; Löwik CW; Verheijen JH
J Bone Miner Res; 1995 Sep; 10(9):1374-84. PubMed ID: 7502710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
